COVID-19 treatment with Evusheld

Evusheld (tixagevimab/cilgavimab) is a preventative treatment given by 2 injections at the same visit that helps prevent COVID-19 in individuals whose bodies have trouble making antibodies.

Table of Contents

Eligibility

Evusheld is used before someone gets COVID-19 and is for individuals ages 12 and older who:

  • weigh more than 88 pounds
  • are not infected with COVID-19
  • have a weakened immune system because of a medical condition or medication
  • have a history of severe reactions to substances in COVID-19 vaccines

If you received a COVID-19 vaccine, you should wait at least 2 weeks to receive Evusheld.

How to access Evusheld

First, talk to your doctor to see if Evusheld is right for you because a prescription is needed.  

Your doctor can help you find a site administering Evusheld by using an in-network referral or by submitting a referral to a participating site – more details listed below. You may also be eligible for the state’s in-home COVID-19 treatment program

If you received the initial lower dose of Evusheld that was recommended prior to the U.S. Food and Drug Administration's Feb. 24 dosage update, talk to your health care provider and schedule to return for an additional 150 mg of tixagevimab and 150 mg of cilgavimab as soon as possible.

Treatment is not a substitute for vaccination

It is important to get vaccinated and get your booster when eligible.

Information for providers

If your patient is eligible for Evusheld, you can refer them in-network, submit a referral to a state-funded site, OR 

  • South Shore Hospital in Weymouth: Complete this form and fax it to 781-624-4099. 
  • Boston Children’s Hospital (Must be under 18): Call 617-355-2170. 
  • Whittier Street Health Center in Boston: Complete this form or call 617-858-2444. 

If you are interested in administering Evusheld at your practice, contact the Department of Public Health (DPH) at covid19.resource.request@mass.gov.

Updates

Feedback